Postoperative complications are similar in glaucoma surgery

Article

Incidence of postoperative complications in eyes with primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) are similar, according to a study published in Archives of Ophthalmology.

Incidence of postoperative complications in eyes with primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) are similar, according to a study published in Archives of Ophthalmology.

Dr Tan Yar-Li et al., Singapore National Eye Centre and Singapore Eye Research Institute, Singapore, investigated the occurrence of postoperative complications and reoperations found in the first year after trabeculectomy and phacotrabeculectomy in eyes with PACG and POAG. The retrospective study looked at 446 patients with PACG and 816 POAG patients who underwent glaucoma operations at a Singapore hospital from January 2001 to December 2004.

Of the 446 subjects with PACG, 112 underwent trabeculectomy and 334 underwent phacotrabeculectomy. Phacotrabeculectomy was performed in 608 of the POAG subjects and 208 underwent trabeculectomy.

There was no significant difference between the POAG and PACG groups, but there was a higher incidence of postoperative complications in the trabeculectomy group compared with the phacotrabeculectomy group. The most frequent complications observed were hypotony with overfiltration, found in 23 cases, followed by 11 cases of bleb leak.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.